Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bromfenac (xibrom) (1 trial)
hyaluronic acid (1 trial)
isoniazid (nydrazid) (1 trial)
rifampin (1 trial)
ciprofloxacin (cipro) (1 trial)
poloxamer 188 (1 trial)
polyethylene glycol (1 trial)
tea tree oil (1 trial)
boceprevir (victrelis) (1 trial)
daclatasvir (daklinza) (1 trial)
dasabuvir (Exviera) (1 trial)
elbasvir (1 trial)
grazoprevir (zepatier) (1 trial)
ledipasvir (Harvoni) (1 trial)
ombitasvir (Viekira Pak) (1 trial)
paritaprevir (viekira pak) (1 trial)
ritonavir (Norvir) (1 trial)
simeprevir (olysio) (1 trial)
sofosbuvir (sovaldi) (1 trial)
telaprevir (incivek) (1 trial)
velpatasvir (Epclusa) (1 trial)
Cataract (Phase 4)
Infections (Phase 4)
Latent Tuberculosis (Phase 4)
Parasitic Diseases (Phase 3)
Tuberculosis (Phase 4)
Trials (4 total)
Trial APIs (21 total)